Stock data
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO) reported revenue of US$33.48M and net income of -US$52.70M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$33.48M | — | -US$51.81M | -US$52.70M | — |
| 2024 | US$2.64M | — | -US$64.30M | -US$61.02M | — |
| 2023 | US$2.76M | — | -US$51.51M | -US$49.12M | — |
| 2022 | US$3.53M | — | -US$32.66M | -US$33.61M | — |
| 2021 | — | — | -US$0.39M | -US$0.38M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.09M | -US$23.75M | — |
| 2026-03-31 | US$0.11M | -US$20.69M | — |
| 2025-12-31 | US$30.92M | US$6.25M | — |
| 2025-09-30 | US$0.86M | -US$20.83M | — |
| 2025-06-30 | US$0.84M | -US$19.36M | — |
| 2025-03-31 | US$0.87M | -US$18.75M | — |
| 2024-12-31 | US$0.25M | -US$16.16M | — |
| 2024-09-30 | US$0.99M | -US$15.43M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.